Dr. Zhi-Ying Wu received her M.D. degree in Medicine from Fujian Medical University in 1990 and Ph.D. degree in Neurology from Tongji Medical University in 1999. From February 2001 to December 2003, she obtained her postdoctoral training at Columbia University in New York. Since 1990 to 2007, Dr. Wu had worked as a resident, attending doctor and chief physician in sequence in Department of Neurology, First Affiliated Hospital, Fujian Medical University. She was introduced as a distinguished professor to Huashan Hospital, Fudan University in 2007. In 2015, she was introduced to Zhejiang University School of Medicine as a Qiushi distinguished professor. Currently, Dr. Wu is a Chief physician, professor and tutor of Ph.D. students in Department of Medical Genetics and Center for Rare Diseases, Second Affiliated Hospital, Zhejiang University School of Medicine. Dr. Wu has long been committed to the screening of causative genes and the study of precision medicine in hereditary rare diseases, pioneering in China’s rare disease research. She has achieved prominent accomplishments in the precise diagnosis and treatment of paroxysmal kinesigenic dyskinesia (PKD) and Wilson’s disease (WD), and is internationally recognized for identifying three causative genes including PRRT2, TMEM151A and COX20. She is the first to report carbamazepine as a specific drug for PKD and demonstrate the efficacy of zinc therapy for pre-symptomatic WD individuals. Prof. Wu has led 10 national natural science foundation projects and has been selected as “Winner of the National Outstanding Youth Science Fund” in 2011. She has been selected as “Winner of the National Outstanding Youth Science Fund” in 2011. Serving as corresponding author, she has published over 170 SCI papers in esteemed international journals, such as Nature Genetics, Brain, Molecular Neurodegeneration, Cell Reports, Neurology, Movement Disorders, Archive of Neurology and others. She has been invited to give keynote or special reports at international academic conferences over 20 times. She has been selected as “National Candidates for the New Century Millions of Talents Project” and “The State Council Special Allowance Experts”. She has been honored with various awards, including the 10th “China Youth Science and Technology Award” and the 9th “China Young Female Scientist Award”. In 2020, the “Innovative Team for Optimization of Diagnosis and Treatment and Mechanism Research of Neurogenetic Diseases” led by Prof. Wu was selected as a Key Domain Innovative Team under the Ministry of Science and Technology’s Innovative Talents Promotion Program.